Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study

Medicine, Metastatic breast cancer, Exemestane, Internal medicine, Oncology, Everolimus, Hormone receptor, Progression-free survival, Breast cancer, Cancer, Gynecology, Aromatase, Chemotherapy